Pediatric lymphomas: overview and diagnostic challenges
Open Access
- 21 December 2024
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 486 (1) , 81-100
Abstract
Only 10% of new lymphoma diagnoses in the USA occur in children < 15 years. Although the same diagnostic criteria apply to both adult and pediatric lymphomas, there are important differences in some lymphoma subtypes. These differences are recognized by the World Health Organization (WHO) with the recent 2022 classification of pediatric tumors including pediatric hematopoietic tumors. Here, we review the WHO classification scheme for pediatric lymphomas and summarize the diagnostic criteria, recent genetic findings, and differences from their adult counterparts for some subtypes including those yet to be included as a definitive subtype. In general, there are differences in relatively frequency, genetic mutation, and prognosis with the pediatric counterpart often having better prognosis. Emerging B-cell lymphomas with recurrent gene alterations such as IRF4 rearrangement and 11q gain/loss chromosomal alterations will be reviewed. The overlapping pathological, clinical, and molecular features between pediatric-type follicular lymphoma (PTFL) and pediatric nodal marginal zone lymphoma (PNMZL) suggesting one disease with broad morphological spectrum will be discussed. The pathogenetic role of EBV in subclassifying Burkitt lymphoma is highlighted. The revised classification of the EBV-positive lymphoproliferative disorders in children is discussed. This review will focus on novel findings, areas of special interest, and diagnostic challenges in pediatric lymphomas.Keywords
Funding Information
- Universitätsklinikum Tübingen
This publication has 110 references indexed in Scilit:
- Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphomaPediatric Blood & Cancer, 2023
- IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B‐cell lymphomaCancer Medicine, 2023
- Molecular features of non‐anaplastic peripheral T‐cell lymphoma in children and adolescentsPediatric Blood & Cancer, 2021
- Rare non‐Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphomaPediatric Blood & Cancer, 2020
- Management of children and adolescents with gray zone lymphoma: A case seriesPediatric Blood & Cancer, 2020
- IRF4 translocation status in pediatric follicular and diffuse large B‐cell lymphoma patients enrolled in Children's Oncology Group trialsPediatric Blood & Cancer, 2019
- IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10Pediatric Blood & Cancer, 2016
- Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patientsInternational Journal of Cancer, 2014
- Epstein–Barr virus presence in pediatric diffuse large B‐cell lymphoma reveals a particular association and latency patterns: Analysis of viral role in tumor microenvironmentInternational Journal of Cancer, 2012
- Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2012